Literature DB >> 21369738

Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.

Hiroshi Katoh1, Keishi Yamashita, Guoqin Wang, Takeo Sato, Takatoshi Nakamura, Masahiko Watanabe.   

Abstract

BACKGROUND: Previous studies have suggested a detrimental prognostic effect of preoperative obstruction proximal to colorectal cancer (CRC). If such a detrimental effect is preserved in each stage of advanced (stage II or III) CRC, we can identify high-risk patients.
METHODS: We enrolled 641 patients with pathologically confirmed advanced CRC (stage II, n = 207; stage III, n = 434) who had undergone curative resection of the primary lesion. The association of preoperative obstruction with clinicopathologic parameters was evaluated. Kaplan-Meier analysis and Cox proportional hazard models were used to estimate the effect of preoperative obstruction on disease-free survival in each stage.
RESULTS: Preoperative obstruction was seen in 63 patients (9.8%) (stage II, n = 16; stage III, n = 47). Multivariable analysis showed that preoperative obstruction was significantly associated with preoperative elevation of carcinoembryonic antigen level in patients with colon cancer (odds ratio = 3.59; P < 0.001), while it was correlated with poor differentiation in patients with rectal cancer (odds ratio = 3.99; P = 0.016). Preoperative obstruction was a significant prognostic factor in stage III CRC (P < 0.001), but not in stage II disease. Multivariable prognostic analysis showed that preoperative obstruction was a remnant independent prognostic factor in stage III CRC. This finding was confirmed by separate analyses of colon and rectal cancer. Preoperative obstruction was associated with systemic recurrence (P = 0.003) rather than peritoneal or local recurrence.
CONCLUSIONS: These findings suggest that preoperative obstruction may predict worse long-term prognosis in patients with stage III CRC and may be a potential clinical marker to identify patients with high-risk stage III CRC.

Entities:  

Mesh:

Year:  2011        PMID: 21369738     DOI: 10.1245/s10434-011-1625-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.

Authors:  Yusuke Okuda; Takaya Shimura; Tomonori Yamada; Yoshikazu Hirata; Ryuzo Yamaguchi; Eiji Sakamoto; Hiromi Kataoka
Journal:  Int J Clin Oncol       Date:  2018-06-15       Impact factor: 3.402

2.  Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients.

Authors:  Gilles Manceau; Thibault Voron; Diane Mege; Valérie Bridoux; Zaher Lakkis; Aurélien Venara; Laura Beyer-Berjot; Solafah Abdalla; Igor Sielezneff; Jeremie H Lefèvre; Mehdi Karoui
Journal:  Langenbecks Arch Surg       Date:  2019-10-10       Impact factor: 3.445

3.  Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.

Authors:  Akira Ooki; Kiwamu Akagi; Toshimasa Yatsuoka; Masako Asayama; Hiroki Hara; Yoji Nishimura; Hiroshi Katoh; Keishi Yamashita; Masahiko Watanabe; Kensei Yamaguchi
Journal:  J Gastrointest Surg       Date:  2017-03-01       Impact factor: 3.452

4.  Preoperative prognostic factors for obstructive colorectal cancer.

Authors:  Jean-Hubert Etienne; Benjamin Salucki; Jean-Marc Bereder; Damien Massalou; Imad Bentellis; Maïlys Goetschy; Patrick Baqué
Journal:  Int J Colorectal Dis       Date:  2022-05-04       Impact factor: 2.571

5.  Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study.

Authors:  Ishibe Atsushi; Ota Mitsuyoshi; Yamaguchi Kazuya; Kaida Syuhei; Kamiya Noriyuki; Momiyama Masashi; Watanabe Akira; Sekizawa Kentaro; Kamimukai Nobuyuki; Sugimasa Natsuko; Watanabe Jun; Ichikawa Yasushi; Kunisaki Chikara; Endo Itaru
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

6.  Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.

Authors:  N Nakayama; K Yamashita; T Tanaka; H Kawamata; A Ooki; T Sato; T Nakamura; M Watanabe
Journal:  Clin Exp Metastasis       Date:  2015-11-12       Impact factor: 5.150

7.  Preoperative constipation is associated with poor prognosis of rectal cancer: a prospective cohort study.

Authors:  Gil-Yong Lee; Sung-Min Lee; Je-Ho Jang; Heung-Kwon Oh; Duck-Woo Kim; Soyeon Ahn; Sung-Bum Kang
Journal:  J Korean Surg Soc       Date:  2013-06-26

8.  Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.

Authors:  Peter F Lenehan; Lisa A Boardman; Douglas Riegert-Johnson; Giovanni De Petris; David W Fry; Jeanne Ohrnberger; Eugene R Heyman; Brigitte Gerard; Arpit A Almal; William P Worzel
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

9.  Investigation of clinical manifestations in korean colorectal cancer patients.

Authors:  Hye Young Koo; Kyu Joo Park; Jae Hwan Oh; Sung Bum Kang; Seong Taek Oh; Woo Yong Lee
Journal:  Ann Coloproctol       Date:  2013-08-29

10.  Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution.

Authors:  Keizo Yamaguchi; Yutaka Ogata; Yoshito Akagi; Kazuo Shirouzu
Journal:  Oncol Lett       Date:  2013-07-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.